Não tratamos a congestão pulmonar e sistêmica na insuficiência cardíaca aguda adequadamente
DOI:
https://doi.org/10.54143/jbmede.v1i3.51Palavras-chave:
Insuficiência Cardíaca, Insuficiência Cardíaca Aguda, IC, Departamento de EmergênciaResumo
A insuficiência cardíaca aguda é uma doença atual, sendo de grande relevância para o sistema de saúde público e privado. As evidências disponíveis demonstram a diminuta aplicação de medidas comprovadamente eficazes, ora condicionadas pelo limitado conhecimento sobre aspectos pouco abordados da doença, sobretudo em publicações para medicina de emergência. Essa revisão será narrativa e focará em reunir as melhores informações para realização do diagnóstico de insuficiência cardíaca no departamento de emergência, avaliação integrada da congestão e fase vulnerável.
Referências
Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol. 2018; 111(3):436-539.
Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa Ket al . Acute heart failure Nature Reviews Disease Primers (2020)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure . European Journal of Heart Failure (2021) 23, 352–380
Arrigo M, Nijst P and Rudiger A. Optimising Heart Failure Therapies in the Acute Setting . Cardiac Failure Review 2018;4(1):38-42
Albuquerque DC, Neto JD, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, et al; Investigadores Estudo BREATHE. I Brazilian Registry of Heart Failure - Clinical aspects, care quality and hospitalization outcomes. Arq Bras Cardiol. 2015;104(6):433-42.
Dokainish, H. et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob. Health 5, e665–e672 (2017).
Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J and Gheorghiade . The vulnerable phase after hospitalization for heart failure Nat. Rev. Cardiol2015
Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey J Am Coll Cardiol HF 2018;6:273–85
Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E et al. Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED CHEST 2015; 148(1):202-210
Platz E, Campbell RT, Clagget B, Lewis EF, Groarke JD, Docherty KF et al . Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes J Am Coll Cardiol HF 2019;7:849–58
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure (2019) 21, 715–731
Matsue Y, Damman K, Voors AA, et al. Time-to-furosemide treat- ment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 2017;69:3042–51.
Boorsma EM, Maaten JMT, Damman K, Dinh Wilfried, Gustafsson Finn, Goldsmith S et al . Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment Nature Reviews Cardiology volume 17, pages 641–655 (2020)
Njoroge JN , Teerlink JR . Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure Circulation Research. 2021;128:1468–1486
McDonagh TA, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal
R.C. Bourge, J.L. Fleg, G.C. Fonarow, et al. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure, Am. J. Med. 126 (8) (2013) 701–708.
Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J et al . AFFIRM- AHF Investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020; 396:1895 - 1904.
JJV McMurray et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 381 (21), 1995-2008. 2019.
Testani J, Chen J, McCauley B, Kimmel S, Shannon R . Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival Circulation. 2010;122:265–272
Mullens W, Abrahams Z, Francis G, Sokos G, Taylor D, Starling R et al . Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure JACC Vol. 53, No. 7, 2009:589 –96
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 JBMEDE - Jornal Brasileiro de Medicina de Emergência
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
